ISBG Submits CBD Trademarks, Works with BioPulse Labs to Expand Distribution onto Amazon.com
Print
Alert
Las Vegas, NV -- December 20, 2018 -- InvestorsHub NewsWire -- International Spirits and Beverage Group Inc. (OTCQB:ISBG) (“ISBG” or the “Company”), a top-tier brand incubator in the Global Wine & Spirits and CBD-Infused Products markets, is excited to announce that 1) Trademark applications have been filed with the United States Patent and Trademark Office (“USPTO”) for the Company’s new CBD products, 2) the distribution footprint for its CBD products will initially include marketplaces driven by BioPulse Labs (“BioPulse”) and Canbiola, Inc. (“Canbiola”), and 3) ISBG is working with BioPulse to establish an expanded distribution footprint including but not limited to Amazon.com and an aggressive trade show circuit.
“The U.S. President is expected to sign the 2018 Farm Bill into law today,” commented ISBG President Alonzo Pierce. “That represents an enormous step forward for this industry and should help to propel investment and positive consumer attitudes toward hemp, cannabis, and CBD moving forward. We are extremely excited about unveiling our new products step-by-step into the marketplace. We have the right partners and an extremely aggressive strategy, and we are set to hit the market at just the right time.”
As noted above, the Company has now officially submitted full-scope Trademark applications to the USPTO through its attorney for the brand designations “Calm P19”, “Calm P20 Extra”, “Charge P19”, “Charge P20 Extra”, “Align P19”, and “Align P20 Extra”. These six types will be available both in CBD Gummy and CBD Beverage form.
Also as noted above, the Company has already put together agreements with both BioPulse and Canbiola to offer these product lines for sale on their respective popular CBD marketplace websites. In addition, the Company is working with BioPulse to expand distribution onto Amazon.com and to aggressively market its CBD products at trade shows over coming quarters.
Mr. Pierce continued, “We will hit the New Year running at full stride, with our shares once again available to Canadian investors and our new CBD segment beginning to roll out for live sales. Overall, 2018 was a great turnaround year for ISBG, and I can’t express how proud I am of our team. We eliminated debt, streamlined the cap table, removed trading limitations in Canada, uplisted onto the Venture Exchange, and expanded our offering to include strong positioning in the CBD market – probably the most desirable growth market on the planet right now.”
